体型与膀胱癌风险:美国国家癌症研究所队列联盟的前瞻性研究汇总分析
该研究 pooled 30 项国际队列研究共 2,533,008 名参与者,评估 BMI、腰围和身高与膀胱癌风险的关联。结果显示,男性中超重和肥胖与膀胱癌风险增加相关(超重 HR 1.08,95%CI 1.04-1.12;肥胖 HR 1.16,95%CI 1.10-1.22),而女性中无显著关联。结论认为较大体型与男性膀胱癌风险增加相关,女性则不然。
要点
- 男性超重和肥胖与膀胱癌风险增加相关(HR 分别为 1.08 和 1.16)。
- 女性中超重和肥胖与膀胱癌风险无显著关联。
- 男性腰围每增加 10 cm,膀胱癌风险 HR 为 1.06(95%CI 1.03-1.08)。
核心结论
- 较大体型与男性膀胱癌风险增加相关,但与女性无关。
研究设计与样本
- 汇总 30 项国际队列研究共 2,533,008 名参与者,采用多变量 Cox 回归按队列和性别分析,随机效应荟萃分析合并结果。
主要发现
- 男性中,超重(BMI 25.0-29.9 kg/m2)和肥胖(BMI ≥30 kg/m2)相比正常体重(BMI 18.5-24.9 kg/m2)的膀胱癌 HR 分别为 1.08(95%CI 1.04-1.12)和 1.16(95%CI 1.10-1.22)。
- 女性中,超重和肥胖的相应 HR 分别为 1.02(95%CI 0.95-1.09)和 1.04(95%CI 0.95-1.14)。
- 男性 BMI 每增加 5 kg/m2 的 HR 为 1.07(95%CI 1.05-1.09),女性为 1.00(95%CI 0.97-1.04)。
- 男性腰围每增加 10 cm 的 HR 为 1.06(95%CI 1.03-1.08),女性为 1.01(95%CI 0.97-1.04)。
- 身高结果与 BMI 和腰围基本一致,男性中有强且一致的证据,女性则不然。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Body size is an established risk factor for several cancers, but associations with bladder cancer risk remain unclear. METHODS: We pooled data from 2,533,008 participants in 30 international cohort studies to assess associations of BMI, waist circumference, and height with bladder cancer risk. Multivariable Cox regression models, including smoking status, duration, and other confounders, were run separately by cohort and sex, and results combined by random-effects meta-analysis. RESULTS: Incident first primary bladder cancer was diagnosed in 15,259 males and 5,188 females. For males, overweight (BMI, 25.0-29.9 kg/m2) and obesity (BMI, ≥30 kg/m2) were associated with increased risk of bladder cancer, with hazard ratios (HRs) of 1.08 (95% CI, 1.04 to 1.12) and 1.16 (95% CI, 1.10 to 1.22), respectively, when compared with normal weight (BMI, 18.5-24.9 kg/m2). The corresponding HR for females were 1.02 (95% CI, 0.95 to 1.09) and 1.04 (95% CI, 0.95 to 1.14), respectively. The HR per 5 kg/m2 increment was 1.07 (95% CI, 1.05 to 1.09) for males and 1.00 (95% CI, 0.97 to 1.04) for females. Higher waist circumference was also associated with increased risk of bladder cancer for males (HR per 10 cm increase 1.06 [95% CI, 1.03 to 1.08]) but not females (HR, 1.01 [95% CI, 0.97 to 1.04]). Results for height were largely consistent with those for BMI and waist circumference, with strong and consistent evidence for males, but not females. CONCLUSION: Larger body size is associated with increased risk of bladder cancer for males, but not females. Public health interventions to prevent overweight and obesity, along with smoking cessation and reduced occupational exposure to bladder carcinogens, are likely to reduce bladder cancer incidence worldwide.
引用
- Body Size and Bladder Cancer Risk: A Pooled Analysis of Prospective Studies From the National Cancer Institute Cohort Consortium. J Clin Oncol. 2026. PMID: 41996653. doi:10.1200/JCO-25-02155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。